The human dopamine D4 receptor (hD 4 R) variants with long tandem repeats in the third intracellular loop have been strongly associated with attention deficit hyperactivity disorder (ADHD) and risk taking behaviors. To understand the potential molecular mechanism underlying the connection, we have investigated the synaptic function of human D 4 R polymorphism by virally expressing the ADHD-linked 7-repeat allele, hD4.7, or its normal counterpart, hD4.4, in the prefrontal cortex (PFC) of D 4 R knockout mice. We found that hD 4 R bound to the SH3 domain of PSD-95 in a state-dependent manner. Activation of hD4.7 caused more reduction of NR1/PSD-95 binding and NR1 surface expression than hD4.4 in PFC slices. Moreover, the NMDAR-mediated excitatory postsynaptic currents (NMDAR-EPSC) in PFC pyramidal neurons were suppressed to a larger extent by hD4.7 than hD4.4 activation. Direct stimulation of NMDARs with the partial agonist D-cycloserine prevented the NMDAR hypofunction induced by hD4.7 activation. Moreover, hD4.7-expressing mice exhibited the increased exploratory and novelty seeking behaviors, mimicking the phenotypic hallmark of human ADHD. D-cycloserine administration ameliorated the ADHD-like behaviors in hD4.7-expressing mice. Our results suggest that oversuppression of NMDAR function may underlie the role of hD4.7 in ADHD, and enhancing NMDAR signaling may be a viable therapeutic strategy to ADHD humans carrying the D4.7 allele.
Introduction
Attention-deficit Hyperactivity disorder (ADHD), a prevalent and debilitating disorder characterized by inattention, hyperactivity, and impulsivity, is highly heritable and multifactorial (Thapar and Cooper, 2015; Hawi et al., 2015) . One established candidate gene is the dopamine D4 receptor (Bobb et al., 2005; Grady et al., 2003; Swanson et al., 2007) . The gene encoding human D4 receptor (hD4R) uniquely contains a large number of polymorphisms in the coding region for the third intracellular loop, which consists of a variable number (2 − 11) of 48-bp proline-rich tandem repeats (VNTR, Van Tol et al., 1992) . The two most common variants contain 4 and 7 repeats (hD4.4, hD4.7), with the global frequency of 64% and 21%, respectively (Chang et al., 1996) . Clinical studies have found a high prevalence of the hD4.7 variant in children diagnosed with ADHD (Grady et al., 2003; Altink et al., 2012; Berry et al., 2013; Trejo et al., 2015) , and in people with personality traits of novelty seeking, risk taking, substance abuse and impulsivity (Ebstein et al., 1996; Benjamin et al., 1996; Li et al., 2004; Reiner and Spangler, 2011) .
The proline-rich repeats in hD4R provide the binding sites for other proteins containing the SH3 domain. So far the molecular mechanism and functional significance of the remarkable VNTR polymorphism of hD4R is poorly understood. D4 receptors are highly enriched in prefrontal cortex (PFC, Mrzljak et al., 1996; Wedzony et al., 2000; Rubinstein et al., 2001 ), a brain region subserving high-level "executive" functions, many of which are disrupted in ADHD (Avale et al., 2004; Batty et al., 2015; Yamaguchi et al., 2015) . The glutamatergic transmission in PFC plays a key role in determining PFC functions (Goldman-Rakic, 1995; Lisman et al., 1998; Popoli et al., 2011; Yuen et al., 2011 Yuen et al., , 2012 . NMDA-type glutamate receptors are anchored to the synaptic membrane by binding to SH3 domain-containing scaffolding proteins, such as PSD-95 (Roche et al., 2001; Wenthold et al., 2003; Prybylowski et al., 2005) . NMDAR dysfunction has been linked to mental disorders including ADHD (Dorval et al., 2007; Jensen et al., 2009; Chang et al., 2014) and autism (Duffney et al., 2015) . Our previous studies in rodents have found that D4R activation modulates NMDAR trafficking and function (Wang et al., 2003) , and this modulation goes awry in a schizophrenia model (Wang et al., 2006) . Administration of methylphenidate (MPH), a dopamine and norepinephrine reuptake inhibitor approved for ADHD treatment, facilitates attention by potentiating PFC NMDAR
